Neo Ivy Capital Management - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 1 filers reported holding MIRATI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,077
+1167.1%
24,720
+1224.8%
0.47%
+715.5%
Q4 2022$85
-100.0%
1,866
-48.3%
0.06%
-78.3%
Q1 2022$296,000
+218.3%
3,612
+542.7%
0.27%
+184.0%
Q3 2020$93,000
-89.4%
562
-93.4%
0.09%
-71.8%
Q2 2020$881,0000.0%8,5540.0%0.33%
-33.0%
Q2 2019$881,0008,5540.50%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders